| scholarly article | Q13442814 |
| P2093 | author name string | J D Katz | |
| M O Kurrer | |||
| S V Pakala | |||
| P2860 | cites work | Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages | Q29618421 |
| Functional diversity of helper T lymphocytes | Q29619415 | ||
| Interleukin 4 amplifies monocyte chemotactic protein and interleukin 6 production by endothelial cells | Q33190257 | ||
| Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction | Q34134530 | ||
| In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice | Q34224719 | ||
| Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice | Q34238473 | ||
| Pancreatic islet-specific T-cell clones from nonobese diabetic mice | Q34313103 | ||
| Anti-α/β T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice | Q34750997 | ||
| Beta cell apoptosis in T cell-mediated autoimmune diabetes | Q35905815 | ||
| Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice | Q36361909 | ||
| Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice | Q36363008 | ||
| Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes | Q36366434 | ||
| Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease | Q36380402 | ||
| Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells | Q36773372 | ||
| Insulin-dependent diabetes mellitus | Q36970581 | ||
| Identification of dying cells--in situ staining | Q40402397 | ||
| Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. | Q40606547 | ||
| Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation? | Q40745649 | ||
| Microcirculation of the islets of Langerhans. Long Beach Veterans Administration Regional Medical Education Center Symposium | Q40971495 | ||
| Postnatal anti-interferon-gamma treatment prevents pancreatic inflammation in transgenic mice with beta-cell expression of interferon-gamma | Q41032597 | ||
| Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches | Q41464299 | ||
| Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody | Q41816592 | ||
| Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma | Q43576523 | ||
| Absence of insulitis and overt diabetes in athymic nude mice with NOD genetic background. | Q44383562 | ||
| Late complications of immune deviation therapy in a nonhuman primate | Q46594595 | ||
| Interleukin-10 drives human monocytes to CD16 positive macrophages. | Q50335933 | ||
| Immune regulation in type 1 diabetes. | Q52048662 | ||
| Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. | Q54214153 | ||
| Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study | Q67298313 | ||
| Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression | Q68300729 | ||
| Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1, 2 antibody | Q68812406 | ||
| Following a diabetogenic T cell from genesis through pathogenesis | Q70488192 | ||
| Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells | Q71829117 | ||
| Complexities in the treatment of autoimmune disease | Q71947990 | ||
| Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice | Q72109469 | ||
| T helper cell subsets in insulin-dependent diabetes | Q72265872 | ||
| The pathogenesis of insulin-dependent diabetes mellitus | Q72827807 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | acute pancreatitis | Q854573 |
| P304 | page(s) | 299-306 | |
| P577 | publication date | 1997-07-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice | |
| P478 | volume | 186 |
| Q43660043 | A concept on the role of Helicobacter pylori infection in autoimmune pancreatitis. |
| Q35822833 | A targeted mutation in the IL-4Ralpha gene protects mice against autoimmune diabetes |
| Q35645080 | Achieving antigen-specific immune regulation |
| Q34828735 | Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3gamma1(Ala-Ala). |
| Q40926796 | Alanine-substituted peptide ligands differ greatly in their ability to activate autoreactive T-cell subsets specific for the wild-type peptide |
| Q33835115 | Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation |
| Q36400329 | An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. |
| Q43886669 | An interleukin-10 gene promoter polymorphism (-592A/C) associated with type 2 diabetes: a North Indian study |
| Q33594140 | Antigen-based immunotherapy for autoimmune disease: from animal models to humans? |
| Q51080285 | Association of IL-10 gene (-1082A>G, -819C>T and -592C>A) polymorphism and its serum level with metabolic syndrome of north Indian subjects. |
| Q44965438 | Association of IL-6, TNF-α and IL-10 gene polymorphisms with type 2 diabetes mellitus |
| Q34765268 | Asthma: an epidemic of dysregulated immunity |
| Q36380584 | Autopathogenic T helper cell type 1 (Th1) and protective Th2 clones differ in their recognition of the autoantigenic peptide of myelin proteolipid protein |
| Q42691926 | Autoreactive T cells promote post-traumatic healing in the central nervous system. |
| Q77567220 | Balancing the Th1/Th2 concept in multiple sclerosis |
| Q77659319 | Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1 |
| Q36401263 | CD4(+) T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice |
| Q40897925 | Characterization and role in experimental systemic lupus erythematosus of T-cell lines specific to peptides based on complementarity-determining region-1 and complementarity-determining region-3 of a pathogenic anti-DNA monoclonal antibody |
| Q34086970 | Characterization of the KRN cell transfer model of rheumatoid arthritis (KRN-CTM), a chronic yet synchronized version of the K/BxN mouse |
| Q33713331 | Colitis in transgenic and knockout animals as models of human inflammatory bowel disease |
| Q77892048 | Control of immune pathology by regulatory T cells |
| Q33859498 | Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation |
| Q34083001 | Cyclin D3 promotes pancreatic β-cell fitness and viability in a cell cycle-independent manner and is targeted in autoimmune diabetes. |
| Q41745135 | Cytokine-directed therapies in multiple sclerosis and experimental autoimmune encephalomyelitis |
| Q41732572 | Cytokines induce the development of functionally heterogeneous T helper cell subsets |
| Q34987307 | Cytokines: promoters and dampeners of autoimmunity |
| Q80373594 | DNA vaccination encoding glutamic acid decarboxylase can enhance insulitis and diabetes in correlation with a specific Th2/3 CD4 T cell response in non-obese diabetic mice |
| Q38178734 | Different subsets of natural killer T cells may vary in their roles in health and disease |
| Q33713280 | Dissecting the role of CD4+ T cells in autoimmune diabetes through the use of TCR transgenic mice |
| Q33723083 | Dominant regulation: a common mechanism of monoclonal antibody induced tolerance? |
| Q44655247 | Effects of deviating the Th2-response in murine mercury-induced autoimmunity towards a Th1-response |
| Q34575350 | Epitope spreading in immune-mediated diseases: implications for immunotherapy |
| Q35746595 | Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype |
| Q74471851 | Genetic association between interleukin-10 gene promoter region polymorphisms and type 1 diabetes age-at-onset |
| Q34023565 | Genetic polymorphisms of cytokine genes in type 2 diabetes mellitus |
| Q30473057 | Genetics of autoimmune diabetes in animal models |
| Q35951526 | IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage |
| Q28270870 | Identification of a novel type 1 diabetes susceptibility gene, T-bet |
| Q77922185 | Immunoregulation of experimental autoimmune encephalomyelitis: editorial overview |
| Q34118463 | Immunotherapy of immune-mediated diabetes. Present and future |
| Q36368009 | In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. |
| Q55068093 | Infectious tolerance. |
| Q43709432 | Influence of the vitamin D plasma level and vitamin D-related genetic polymorphisms on the immune status of patients with type 1 diabetes: a pilot study |
| Q41698368 | Interleukin-10: The missing link in asthma regulation? |
| Q77402583 | Interleukin-4 deficiency facilitates development of experimental myasthenia gravis and precludes its prevention by nasal administration of CD4+ epitope sequences of the acetylcholine receptor |
| Q30306972 | Intestinal parasitism terminates self tolerance and enhances neonatal induction of autoimmune disease and memory |
| Q38691482 | Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation |
| Q33794336 | Mouse Models for Type 1 Diabetes |
| Q34288977 | NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and Inflammation |
| Q36526442 | Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype |
| Q78028331 | Oral tolerance by a high dose OVA in BALB/c mice is more pronounced and persistent in Th2-mediated immune responses than in Th1 responses |
| Q33867150 | Pathways of T cell pathology in models of chronic intestinal inflammation |
| Q44175870 | Prior Bordetella pertussis infection modulates allergen priming and the severity of airway pathology in a murine model of allergic asthma. |
| Q30276673 | Regulatory T Cells Control Th2-Dominant Murine Autoimmune Gastritis |
| Q34374560 | Regulatory T cells and allergic asthma |
| Q47848881 | Role of interferon-gamma in the pathogenesis of LCMV-induced meningitis: unimpaired leucocyte recruitment, but deficient macrophage activation in interferon-gamma knock-out mice |
| Q77725121 | Selective immunotherapy of IDDM: a discussion based on new findings from the RIP-LCMV model for autoimmune diabetes |
| Q33867186 | Spontaneous chronic colitis in TCR alpha-mutant mice; an experimental model of human ulcerative colitis |
| Q84452304 | Study of interleukin-10 promoter region polymorphisms (-1082A/G, -819T/C and -592A/C) in type 1 diabetes mellitus in Turkish population |
| Q41039671 | Suppression of spontaneous uveoretinitis development by non-immunopathogenic peptide immunization |
| Q36400646 | T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells |
| Q36376495 | T helper 1 and T helper 2 cells are pathogenic in an antigen-specific model of colitis |
| Q35158939 | Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets |
| Q34565713 | Th17 cells can provide B cell help in autoantibody induced arthritis |
| Q37370178 | Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. |
| Q74307371 | The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome |
| Q77922215 | The comeback of the elusive "suppressor" cell: an update on the regulatory network in EAE |
| Q43640297 | The critical role of interleukin 4 but not interferon gamma in the pathogenesis of colitis in T-cell receptor alpha mutant mice |
| Q37776696 | The dangerous liaison between iNKT cells and dendritic cells: does it prevent or promote autoimmune diseases? |
| Q34573771 | The enemy within: keeping self-reactive T cells at bay in the periphery |
| Q34452348 | The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. |
| Q33784067 | The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy |
| Q36017123 | The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model |
| Q28485365 | Transcriptome analysis of epigenetically modulated genome indicates signature genes in manifestation of type 1 diabetes and its prevention in NOD mice |
| Q37188345 | Transfusion of nonobese diabetic mice with allogeneic newborn blood ameliorates autoimmune diabetes and modifies the expression of selected immune response genes |
| Q77922211 | Tumour necrosis factor-alpha and lymphotoxin-alpha in the pathology of experimental autoimmune encephalomyelitis: is either one responsible or is there another ligand-mediating disease? |
| Q33606814 | Type I (insulin-dependent) diabetes is a Th1- and Th2-mediated autoimmune disease |
| Q33269680 | Type II collagen without adjuvant induces eosinophilic arthritis |
| Q34498188 | Understanding autoimmune diabetes: insights from mouse models. |
Search more.